Rainmed Medical Limited (HKG:2297)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.241
+0.012 (5.24%)
Apr 29, 2026, 4:08 PM HKT
32.42%
Market Cap 320.91M
Revenue (ttm) 21.34M
Net Income (ttm) -85.78M
Shares Out 1.40B
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 773,000
Average Volume 1,087,850
Open 0.229
Previous Close 0.229
Day's Range 0.229 - 0.243
52-Week Range 0.150 - 0.530
Beta 0.68
RSI 36.03
Earnings Date Mar 31, 2026

About Rainmed Medical

Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2014
Employees 214
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2297
Full Company Profile

Financial Performance

In 2025, Rainmed Medical's revenue was 19.18 million, a decrease of -51.85% compared to the previous year's 39.82 million. Losses were -77.08 million, -32.08% less than in 2024.

Financial numbers in CNY Financial Statements

News

There is no news available yet.